Pathway-Based Analysis of Essential Metabolic Enzymes as Drug Targets
This study identifies the essential metabolic enzyme PabB as a promising drug target for tuberculosis and utilizes computational pathway analysis and molecular docking to screen FDA-approved drugs, ultimately highlighting Ligand 5 and Ligand 27 as potential candidates for drug repurposing.